“Single Agent and Synergistic Activity of Maritoclax with ABT-263 in Nasopharyngeal Carcinoma (NPC) Cell Lines”, tlsr, vol. 31, no. 3, pp. 1–13, Oct. 2020, doi: 10.21315/tlsr2020.31.3.1.